WO1999022763A3 - Immunomodulateurs encapsules utilises comme adjuvants de vaccins - Google Patents
Immunomodulateurs encapsules utilises comme adjuvants de vaccins Download PDFInfo
- Publication number
- WO1999022763A3 WO1999022763A3 PCT/US1998/023313 US9823313W WO9922763A3 WO 1999022763 A3 WO1999022763 A3 WO 1999022763A3 US 9823313 W US9823313 W US 9823313W WO 9922763 A3 WO9922763 A3 WO 9922763A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- encapsulated
- immunomodulator
- vaccine adjuvants
- useful
- adjuvant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2006—IL-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
- A61K2039/55533—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
- A61K2039/55538—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98955231A EP1027071A2 (fr) | 1997-10-31 | 1998-11-02 | Immunomodulateurs encapsules utilises comme adjuvants de vaccins |
CA002307541A CA2307541A1 (fr) | 1997-10-31 | 1998-11-02 | Immunomodulateurs encapsules utilises comme adjuvants de vaccins |
IL13548098A IL135480A0 (en) | 1997-10-31 | 1998-11-02 | Encapsulated immunomodulators useful as vaccine adjuvants |
AU12084/99A AU1208499A (en) | 1997-10-31 | 1998-11-02 | Encapsulated immunomodulators useful as vaccine adjuvants |
JP2000518694A JP2001521908A (ja) | 1997-10-31 | 1998-11-02 | ワクチンアジュバントとして有用な封入された免疫調節物質 |
AU2003200723A AU2003200723B2 (en) | 1997-10-31 | 2003-02-28 | Encapsulated immunomodulators useful as vaccine adjuvants |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96240797A | 1997-10-31 | 1997-10-31 | |
US08/962,407 | 1997-10-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999022763A2 WO1999022763A2 (fr) | 1999-05-14 |
WO1999022763A3 true WO1999022763A3 (fr) | 1999-08-05 |
Family
ID=25505819
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1998/023313 WO1999022763A2 (fr) | 1997-10-31 | 1998-11-02 | Immunomodulateurs encapsules utilises comme adjuvants de vaccins |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1027071A2 (fr) |
JP (1) | JP2001521908A (fr) |
AU (1) | AU1208499A (fr) |
CA (1) | CA2307541A1 (fr) |
IL (1) | IL135480A0 (fr) |
WO (1) | WO1999022763A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA06009805A (es) * | 2004-02-27 | 2007-04-02 | Vaxconsulting | Peptidos de interleucina 1 beta y factor de necrosis tumoral alfa y metodo de tratamiento utilizando los mismos. |
EP1928419A1 (fr) * | 2005-09-30 | 2008-06-11 | Lipoxen Technologies Limited | Compositions vaccinales liposomales multivalentes comprenant des antigenes polysaccharides et un adjuvant proteique |
EP2244695A1 (fr) * | 2007-12-07 | 2010-11-03 | Novartis AG | Compositions utilisées pour induire des réponses immunitaires |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03170498A (ja) * | 1989-11-29 | 1991-07-24 | Teikoku Hormone Mfg Co Ltd | ペプチドおよびこのペプチドを含有する薬剤 |
WO1997049423A2 (fr) * | 1996-06-24 | 1997-12-31 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Composition de vaccin contre la grippe encapsulee dans des liposomes et leur procede de fabrication |
-
1998
- 1998-11-02 JP JP2000518694A patent/JP2001521908A/ja active Pending
- 1998-11-02 CA CA002307541A patent/CA2307541A1/fr not_active Abandoned
- 1998-11-02 WO PCT/US1998/023313 patent/WO1999022763A2/fr not_active Application Discontinuation
- 1998-11-02 AU AU12084/99A patent/AU1208499A/en not_active Abandoned
- 1998-11-02 IL IL13548098A patent/IL135480A0/xx not_active IP Right Cessation
- 1998-11-02 EP EP98955231A patent/EP1027071A2/fr not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03170498A (ja) * | 1989-11-29 | 1991-07-24 | Teikoku Hormone Mfg Co Ltd | ペプチドおよびこのペプチドを含有する薬剤 |
WO1997049423A2 (fr) * | 1996-06-24 | 1997-12-31 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Composition de vaccin contre la grippe encapsulee dans des liposomes et leur procede de fabrication |
Non-Patent Citations (2)
Title |
---|
DATABASE WPI Section Ch Week 9136, Derwent World Patents Index; Class B04, AN 91-262316, XP002104336 * |
LIMOR C ET AL: "Characterization of PLGA microspheres for the controlled delivery of IL-1alpha for tumor immunotherapy", JOURNAL OF CONTROLLED RELEASE, vol. 43, no. 2-3, 18 January 1997 (1997-01-18), pages 261-272, XP004069894 * |
Also Published As
Publication number | Publication date |
---|---|
IL135480A0 (en) | 2001-05-20 |
EP1027071A2 (fr) | 2000-08-16 |
CA2307541A1 (fr) | 1999-05-14 |
AU1208499A (en) | 1999-05-24 |
WO1999022763A2 (fr) | 1999-05-14 |
JP2001521908A (ja) | 2001-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001039803A3 (fr) | Muteines de l'interleukine 1 utiles comme adjuvants de vaccins | |
FR2686896B1 (fr) | Mutant attenue de listeria monocytogenes; souche recombinante de listeria monocytogenes, utilisation comme vecteurs heterologues d'antigenes vaccinal et utilisation comme vaccin ou composition diagnostique. | |
CA2143823A1 (fr) | Analogues synthetiques de peptides, modifies pour la reversion, l'inversion et la reversion-inversion | |
DK1090033T3 (da) | Partikler af HCV-kappeproteiner: Anvendelse til vaccination | |
ATE392904T1 (de) | Pharmazeutische zusammensetzung zur immunstimulation und zur zubereitung von impfstoffen enthaltend ein antigen, und als adjuvantien ein immunogenes oligodesoxynukleotid und ein polykationisches polypeptid | |
WO2001095919A3 (fr) | Virus recombinant non replicant exprimant gm-csf et utilisation de celui-ci pour ameliorer des reponses immunitaires | |
GB2303854B (en) | Helicobacter proteins and vaccines | |
NZ331651A (en) | BSW17 peptide immunogens for vaccination against and treatment of allergy | |
EP1088830A3 (fr) | Particules de l'antigène de surface de l'hépatitie B | |
DE69943170D1 (de) | Immunologische Zusammensetzung und Impfstoffe, die einen auf N-Formyl-Methionyl Peptide bestehenden Adjuvans enthalten | |
AU7980794A (en) | Methods and compositions for microencapsulation of antigens for use as vaccines | |
CA2224724A1 (fr) | Vaccin purifie contre une infection par flavivirus | |
EP1611897A3 (fr) | Cellules entières ou lysées d'insecte utilisées comme adjuvants d'antigènes | |
FI920132A0 (fi) | Stabila vaccinkompositioner innehaollande interleukiner. | |
NZ309659A (en) | Composition comprising LbeIF4A and/or LmeIF4A polypeptides (Leishmania antigen) and methods for enhancing immune responses | |
HUP0500238A2 (hu) | Interleukin-12 alkalmazása állatgyógyászati vakcina adjuvánsként | |
ATE275421T1 (de) | Interleukin-12 und herpes simplex virusantigen enthaltende impfstoffe | |
BR0103887A (pt) | Composições imunogênicas contendo microesferas biodegradáveis encapsulando antìgenos, vetores gênicos e adjuvantes | |
DE69836744D1 (de) | Gruppe a streptokokken-impfstoff | |
ATE287957T1 (de) | Peptide abgeleitet vom bindungs (g) protein des respiratorisches synzytialvirus | |
WO1999022763A3 (fr) | Immunomodulateurs encapsules utilises comme adjuvants de vaccins | |
EP0236977A3 (fr) | Vaccins contre la diarrhée bovine virale et le choléra porcin | |
WO2002034287A3 (fr) | Nouvelles formulations de vaccin therapeutique | |
WO2000006198A3 (fr) | Adjuvant comprenant un tensioactif pulmonaire | |
SE9604296D0 (sv) | New pharmaceutical formulation of polypeptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 135480 Country of ref document: IL |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA IL JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA IL JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998955231 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2307541 Country of ref document: CA Ref country code: CA Ref document number: 2307541 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 518694 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12084/99 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 1998955231 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998955231 Country of ref document: EP |